Payments to Acquire Property, Plant, and Equipment of Celldex Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Celldex Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Celldex Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $265,000, a 23% decline year-over-year.
  • Celldex Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $2,714,000, a 41% increase from 2024.
  • Celldex Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,919,000, a 5.6% increase from 2023.
  • Celldex Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,818,000, a 0.55% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Celldex Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,714,000 +$795,000 +41% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $1,919,000 +$101,000 +5.6% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $1,818,000 -$10,000 -0.55% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $1,828,000 +$579,000 +46% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $1,249,000 -$303,000 -20% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $1,552,000 +$821,000 +112% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $731,000 -$82,000 -10% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $813,000 -$975,000 -55% 01 Jan 2018 31 Dec 2018 10-K 29 Mar 2021 2020 FY
2017 $1,788,000 -$963,000 -35% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
2016 $2,751,000 -$2,125,000 -44% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $4,876,000 +$2,947,000 +153% 01 Jan 2015 31 Dec 2015 10-K 07 Mar 2018 2017 FY
2014 $1,929,000 -$2,290,000 -54% 01 Jan 2014 31 Dec 2014 10-K 14 Mar 2017 2016 FY
2013 $4,219,000 +$3,916,000 +1292% 01 Jan 2013 31 Dec 2013 10-K/A 25 Feb 2016 2015 FY
2012 $303,000 -$206,000 -40% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
2011 $509,000 -$1,591,000 -76% 01 Jan 2011 31 Dec 2011 10-K 03 Mar 2014 2013 FY
2010 $2,100,000 01 Jan 2010 31 Dec 2010 10-K 08 Mar 2013 2012 FY

Celldex Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $265,000 -$79,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $344,000 -$241,000 -41% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $585,000 +$10,000 +1.7% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $575,000 +$8,000 +1.4% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $567,000 +$332,000 +141% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $235,000 +$49,000 +26% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $186,000 -$73,000 -28% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $259,000 -$115,000 -31% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $374,000 -$166,000 -31% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $540,000 -$1,021,000 -65% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $1,561,000 +$1,366,000 +701% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $195,000 +$33,000 +20% 01 Jan 2014 31 Mar 2014 10-Q 29 Apr 2015 2015 Q1
Q1 2013 $162,000 +$120,000 +286% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q1 2012 $42,000 -$160,000 -79% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q1 2011 $202,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.